Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinically Relevant Outcomes With Romiplostim in Patients With Solid Tumors and Persistent Chemotherapy Induced Thrombocytopenia.
Journal: American journal of hematology
Published: May 04, 2026
Medical Management of Acute Venous Thromboembolism.
Journal: Seminars in interventional radiology
Published: December 22, 2025
Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer.
Journal: European journal of internal medicine
Published: September 23, 2024
Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers.
Journal: Gynecologic oncology reports
Published: February 20, 2024
Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population.
Journal: Current oncology reports
Published: January 03, 2022
Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use.
Journal: Research and practice in thrombosis and haemostasis
Published: September 26, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Journal: British journal of haematology
Published: June 03, 2021
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience.
Journal: Research and practice in thrombosis and haemostasis
Published: February 25, 2019
A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: January 03, 2019
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.
Journal: Clinical genitourinary cancer
Published: July 20, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026